Recent Landmark Trials in Gynecologic Cancer: Optimizing Combination or Sequencing of Systemic and Radiation Therapies [0.03%]
近期妇科肿瘤领域里程碑式临床试验：系统性治疗与放疗联合或序贯的优化
Lara Hathout,Eric Leung,Neil K Taunk et al.
Lara Hathout et al.
Does time to retreatment matter? An NTCP model to predict radionecrosis after repeat SRS for recurrent brain metastases incorporating time-dependent discounted dose [0.03%]
retreat时间对放射性脑病的影响及复发脑转移瘤立体定向放疗后放射性脑病的预测模型
Manju Sharma,Issam El Naqa,Penny K Sneed
Manju Sharma
Purpose: To develop and compare normal tissue complication probability (NTCP) models for recurrent brain metastases (BMs) treated with repeat single-fraction stereotactic radiosurgery (SRS), considering time-dependent dis...
Brachytherapy Seed Placement by Robotic Bronchoscopy with Cone-Beam CT Guidance for Peripheral Lung Cancer: A Human Cadaveric Feasibility Pilot [0.03%]
带锥形束CT引导的机器人支气管镜技术在尸体上植入肺癌外围区域的放射性粒子的可行性研究
Ardian Latifi,Michael Roumeliotis,Sarah Quirk et al.
Ardian Latifi et al.
Purpose: This study evaluates the feasibility of utilizing robotic-assisted bronchoscopy with cone beam computed tomography (RB-CBCT) platform to perform low-dose-rate brachytherapy implants (LDR-BT) in a mechanically ven...
SEMI-AUTOMATED EXTRACTION OF RESEARCH TOPICS AND TRENDS FROM NCI FUNDING IN RADIOLOGICAL SCIENCES FROM 2000-2020 [0.03%]
基于2000-2020年美国放射学研究国家基金的科研主题和趋势的半自动提取技术
Mark H Nguyen,Peter G Beidler,Joseph Tsai et al.
Mark H Nguyen et al.
Background: Investigators and funding organizations desire knowledge on topics and trends in publicly funded research but current efforts for manual categorization have been limited in breadth and depth of understanding. ...
Long-Term Outcomes of Radiation Monotherapy Versus Combined Radiation Monotherapy + Hormone Therapy in Low-Risk Early-Stage Breast Cancer Patients 70 Years or Older After Breast-Conserving Surgery [0.03%]
保乳术后对70岁以上早期低危乳腺癌患者放射治疗与辅助内分泌治疗的长期预后研究
Astrid D Morris,Douglas A Hanes,Henry G Kaplan
Astrid D Morris
Purpose: Standard therapy for breast cancer after breast-conserving surgery is radiation therapy (RT) plus hormone therapy (HT). For patients with a low-risk of recurrence, there is an interest in deescalating therapy. ...
Randomized Evaluation of the PET-Adjusted IMRT for NSCLC Trial (REPAINT) [0.03%]
NSCLC的PET校正型IMRT随机对照研究（REPAINT）
Nitin Ohri,William R Bodner,Rafi Kabarriti et al.
Nitin Ohri et al.
Background: Standard radiotherapy (RT) for locally advanced NSCLC (LA-NSCLC) employs a uniform dose of approximately 60 Gy. Recent trials demonstrated that radiotherapy dose escalation may not improve outcomes and may cau...
Discordance in acute gastrointestinal toxicity between synchrotron-based proton and linac-based electron ultra-high dose rate irradiation [0.03%]
基於同步加速器的质子和直线加速器电子超高速率辐照急性胃肠毒性差异研究
Kevin Liu,Uwe Titt,Nolan Esplen et al.
Kevin Liu et al.
Purpose: Proton FLASH has been investigated using cyclotron and synchrocyclotron beamlines but not synchrotron beamlines. We evaluated the impact of dose rate (ultra-high [UHDR] vs. conventional [CONV]) and beam configura...
Dosimetric comparison of CyberKnife and conventional linac prostate SBRT plans: analysis of the PACE-B Study [0.03%]
基于PACE-B研究的CyberKnife与常规直线加速器前列腺SBRT计划剂量分析比较
Ragu Ratnakumaran,Archana Sasitharan,Asadullah Khan et al.
Ragu Ratnakumaran et al.
Purpose: In the PACE-B study, a non-randomised comparison of toxicity outcomes between stereotactic body radiotherapy (SBRT) platforms revealed fewer urinary side-effects with CyberKnife (CK) compared to conventional lina...
The Determinants of Toxicity in the Treatment of Prostate Cancer with a Focal, Intraprostatic "Microboost" [0.03%]
局灶性前列腺内“微增强”治疗前列腺癌的毒性决定因素分析
Krishnan R Patel,Alan Dal Pra,Erich P Huang et al.
Krishnan R Patel et al.
Purpose: A single phase III trial has demonstrated that prostate radiotherapy with a focal, intra-prostatic "microboost" can improve disease control without an overall increase in toxicity. It is unclear how these results...
Embracing the Future of Clinical Trials in Radiotherapy: An NRG Oncology CIRO Technology Retreat Whitepaper on Pioneering Technologies and AI-Driven Solutions [0.03%]
拥抱放射治疗临床试验的未来：NRG肿瘤学CIRO技术休养站关于开创性技术和人工智能驱动解决方案的白皮书
Ying Xiao,Stanley Benedict,Yunfeng Cui et al.
Ying Xiao et al.
This white paper examines the potential of pioneering technologies and artificial intelligence (AI)-driven solutions in advancing clinical trials involving radiotherapy. As the field of radiotherapy evolves, the integration of cutting-edge ...